COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,285 Articles (22,759 medRxiv, 8,526 bioRxiv)

Most recent first Previous |  Page 446: Articles 4451-4460  | Next

An Azapeptide Platform in Conjunction with Covalent Warheads to Uncover High-Potency Inhibitors for SARS-CoV-2 Main Protease
Khatua, K., Alugubelli, Y. R., Yang, K., Reddy, V., Blankenship, L., Coleman, D., Atla, S., Chaki, S., Geng, Z., Ma, X., Xiao, J., Chen, P.-H., Cho, C.-C., Vatansever, E. C., Ma, Y., Yu, G., Neuman, B., Xu, S., Liu, W. R.
10.1101/2023.04.11.536467 — Posted: 2023-04-12
Analysis of SARS-CoV-2 Recombinant Lineages XBC and XBC.1 in the Philippines and Evidence for Delta-Omicron Co-infection as a Potential Origin
Pangilinan, E. A. R., Egana, J. M. C., Mantaring, R. J. Q., Telles, A. J. E., Tablizo, F. A., Lapid, C. M., Yangzon, M. S. L., Endozo, J. J. S., Padilla, K. S. A. R., Nipales, J. E., Carandang, L. C. D. L., Enriquez, Z. M. R., Barot, T. A. U., Manlimos, R. A., Mangonon, K. N. P., Plantig, M. E. L., Balucio, J. E. B., Lustria, J. M. B., Araiza, S. M. M., Llames, J.-H. S., Punayan, K. P., Serrano, R. P., Drueco, A. M., Lagnas, H. T., Bistayan, P. A., Aguilar, A. C., Charisse Apo, J. G., Austria, Y. V. D., Bustamante, N. F. M., Caelian, A. J. R., Fernandez, R. E., Galilea, X. A., Gamboa, M. M., Gervacio, C. J. A., Mollejon, Z. V., Pineda, J. P. N., Rico, K. B., Yap, J. M. C., Abad, M. C. S., Maralit, B. A., Ayes, M. E. C., Cutiongco-de la Paz, E. M., Saloma, C. P.
10.1101/2023.04.12.534029 — Posted: 2023-04-12
The Impact Of COVID-19 on Health Financing in Kenya
Kairu, A., Orangi, S., Mbuthia, B., Arwah, B., Guleid, F., Keru, J., Vilcu, I., Musuva, A., Ravishankar, N., Barasa, E.
10.1101/2023.04.05.23288177 — Posted: 2023-04-11
Effectiveness of mRNA COVID-19 monovalent and bivalent vaccine booster doses against Omicron severe outcomes among adults aged >=50 years in Ontario, Canada
Grewal, R., Buchan, S. A., Nguyen, L., Nasreen, S., Austin, P. C., Brown, K. A., Gubbay, J., Lee, N., Schwartz, K. L., Tadrous, M., Wilson, K., Wilson, S. E., Kwong, J. C., on behalf of the CIRN Provincial Collaborative Network investigators
10.1101/2023.04.11.23288403 — Posted: 2023-04-11
A methodological framework for assessing the benefit of SARS-CoV-2 vaccination following previous infection: case study of five to eleven year olds in the UK
Pagel, C., Wilde, H., Tomlinson, C., Mateen, B. A., Brown, K.
10.1101/2023.04.11.23288409 — Posted: 2023-04-11
Infants and young children generate more durable antibody responses to SARS-CoV-2 infection than adults
Joshi, D., Nyhoff, L. E., Zarnitsyna, V. I., Moreno, A., Manning, K., Linderman, S., Burrell, A., Stephens, K., Norwood, C., Mantus, G. E., Ahmed, R., Anderson, E. J., Staat, M. A., Suthar, M. S., Wrammert, J.
10.1101/2023.04.10.23288360 — Posted: 2023-04-11
Comprehensive analysis of nasal IgA antibodies induced by intranasal administration of the SARS-CoV-2 spike protein
Waki, K., Tani, H., Saga, Y., Shimada, T., Yamazaki, E., Koike, S., Okada, N., Isobe, M., Kurosawa, N.
10.1101/2023.04.10.536311 — Posted: 2023-04-11
Global surveillance of novel SARS-CoV-2 variants
Patel, S., Cumming, F., Mayers, C., Charlett, A., Riley, S.
10.1101/2023.04.10.23288358 — Posted: 2023-04-10
A cross-sectional study of the association between COVID-19 infection and psychological distress in Japanese workers
Tesen, H., Konno, Y., Tateishi, S., Tsuji, M., Ogami, A., Nagata, T., Matsugaki, R., Yoshimura, R., Fujino, Y., Mafune, K.
10.1101/2023.04.08.23288312 — Posted: 2023-04-10
Unbiased spectral cytometry immunome characterization predicts COVID-19 mRNA vaccine failure in older adults and patients with lymphoid malignancies.
HERNANDEZ-VAZQUEZ, J., CAL-SABATER, P., ARRIBAS-RODRIGUEZ, E., FIZ-LOPEZ, A., PEREZ-SEGURADO, C., MARTIN-MUNOZ, A., DE PRADO-SANTOS, A., DE LA FUENTE-GRACIANI, I., PEREZ-GONZALEZ, S., GUTIERREZ, S., TELLERIA, P., NOVOA, C., ROJO-RELLO, S., GARCIA-BLESA, A., SEDANO, R., MARTINEZ-GARCIA, A. M., GARCINUNO-PEREZ, S., DOMINGUEZ-GIL, M., HERNAN-GARCIA, C., GUERRA, M. M., MUNOZ-SANCHEZ, E., BARRAGAN-PEREZ, C., DIEZ-MORALES, S., CASAZZA-DONNARUMMA, O., RAMOS-POLLO, D., SANTAMARTA-SOLLA, N., ALVAREZ-MANZANARES, P. M., BRAVO, S., GARCIA-ALONSO, C., TESEDO-NIETO, A., LOPEZ-MORENO, E. C., CABRERA-SANZ, M.
10.1101/2023.04.10.23288350 — Posted: 2023-04-10

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).